Taizhou Zecen Biotech Co.,Ltd.
| Payment Terms | L/C, D/A, D/P, T/T, Western Union, MoneyGram |
| Supply Ability | 5000 Set/Sets per Month |
| Delivery Time | 10 workdays |
| Packaging Details | Carton package |
| Name | cTnl+Myo+CK-MB |
| Analyzer | POClia in Zecen |
| Storage | 2-8°C |
| Sample | Serum |
| Applicable departments | Chest Pain Center, Cardiology Department, Emergency Department, ICU, CCU, Geriatric Department, Respiratory Department, etc. |
| Brand Name | Zecen |
| Model Number | POCT |
| Certification | CE, ISO13485 |
| Place of Origin | China |
View Detail Information
Explore similar products
Neurofilament Protein (N-F) —AD7c-NTP in Fully Automated Immunoassay Analyzer
High Sensitive Cardiac Troponin (Hs-CTn) Diagnostic Lab Reagents For Fully
Thymidine Kinase (TK1) Diagnostic Lab Reagents In Fully Automated Immunoassay
CE TT3 Thyroid Test For Chemiluminescence Immunoassay Analyzer IVD Reagents
Product Specification
| Payment Terms | L/C, D/A, D/P, T/T, Western Union, MoneyGram | Supply Ability | 5000 Set/Sets per Month |
| Delivery Time | 10 workdays | Packaging Details | Carton package |
| Name | cTnl+Myo+CK-MB | Analyzer | POClia in Zecen |
| Storage | 2-8°C | Sample | Serum |
| Applicable departments | Chest Pain Center, Cardiology Department, Emergency Department, ICU, CCU, Geriatric Department, Respiratory Department, etc. | Brand Name | Zecen |
| Model Number | POCT | Certification | CE, ISO13485 |
| Place of Origin | China | ||
| High Light | CTnl+Myo+CK-MB diagnostic reagents ，diagnostic reagents CE ，Zecen clinical diagnostic reagents | ||
POCT Reagents of cTnl+Myo+CK-MB: Myocardial infarction and myocardial injury detection indicators
Clinical Significance of cTnl:
AMI diagnosis "gold standard"
AMI to determine infarct size and carry out risk stratification
Clinical Significance of Myo:
The most important indicator for early negative exclusion of AMI.
AMI recurrence detection, the most sensitive indicator for reperfusion therapy detection.
Clinical Significance of CK-MB:
Early diagnosis of AMI and risk stratification.
The most valuable marker of non-ST-segment elevation AMI
Acute myocardial injury is a very common clinical disease, including acute coronary syndrome (ACS), various acute myocardial infarction (AMI), unstable angina and myocarditis, which seriously endanger human health and quality of life.
Myocardial infarction refers to the reduction or interruption of coronary blood supply on the basis of coronary artery disease, causing the corresponding severe and persistent acute ischemic necrosis of the myocardium. The clinical manifestations are sudden, severe and persistent retrosternal pain, characteristic electrocardiogram dynamic evolution and increase of cardiac markers, and complications such as arrhythmia, heart failure, and shock may occur, which are often life-threatening. Symptoms of myocardial infarction are chest pain and tightness in the chest. The incentives are generally, excessive fatigue, emotional agitation, overeating, major surgery or hemorrhagic shock. In terms of age, middle-aged men between the ages of 45 and 60 are at high risk for myocardial infarction.
In recent years, more and more products have been combined to detect the three indicators of creatine kinase isoenzyme MB, cardiac troponin and myoglobin, and they are gradually accepted by the clinic. item".
| Test item | cTnl+Myo+CK-MB |
| Specification | 24 Test/Box for POClia |
| Component | Magnetic Beads |
| cTnl+Myo+CK-MB Anti | |
| Substrate | |
| Washing solution | |
| Pipetting Tip | |
| Magnetic Tube | |
| Sample material | Serum |
| Storage | 2-8℃ |
Other Kind of Reagents we can provide:
| Thyroid | TSH |
| TT3 | |
| TT4 | |
| FT3 | |
| FT4 | |
| TGAb | |
| TPOAb | |
| TRAb | |
| TG | |
| Fertility | FSH |
| PRL | |
| LH | |
| E2 | |
| TESTO | |
| PROG | |
| HCG | |
| P/H-hcg | |
| AMH | |
| Glycometabolism & Hypophyseal Hormone | C-P |
| INS | |
| Hepatic Fibrosis | PIIINP |
| HA | |
| LN | |
| CIV | |
| Tumor Markers | CEA |
| AFP | |
| CA125 | |
| CA19-9 | |
| CA15-3 | |
| CA50 | |
| CA72-4 | |
| CA242 | |
| T-PSA | |
| F-PSA | |
| TK1 | |
| FERRITIN | |
| SCC | |
| NSE | |
| CYFRA21-1 | |
| HE4 | |
| S100 | |
| Hp-Ab | |
| TPS | |
| TNF-α | |
| GP73 | |
| PIVKAⅡ | |
| PACP | |
| Inflammation Monitoring | IL-6 |
| PCT | |
| CRP | |
| CAA | |
| Cardiac | cTn |
| MYO | |
| CK-MB | |
| HFABP | |
| NT-pro-BNP | |
| D-Dimer | |
| HCY | |
| BNP | |
| Lp-pla2 | |
| ST2 | |
| TORCH | |
| Infectious | HBsAg |
| HBsAb | |
| HBeAg | |
| HBeAb | |
| HBcAb | |
| Anti-HCV | |
| Anti-HIV | |
| Anti-TP | |
| NP-IgG | |
| NP-IgM | |
| Kidney Function | NGAL |
| H-ALB | |
| RBP | |
| Cys-C | |
| β2-MG | |
| Gastric Mucosa Function | PGⅠ/Ⅱ |
| PRO-GRP | |
| GRP-17 |
Company Details
Business Type:
Manufacturer
Year Established:
2011
Employee Number:
300~500
Ecer Certification：
Active Member
Zecen Biotech CO., LTD., founded in 2011, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. Zecen focus on the Chemiluminescent immunoassay (CLIA) field. With all products CE marked, our market presence currently spreads from across China to oth... Zecen Biotech CO., LTD., founded in 2011, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. Zecen focus on the Chemiluminescent immunoassay (CLIA) field. With all products CE marked, our market presence currently spreads from across China to oth...
Get in touch with us
Leave a Message, we will call you back quickly!